Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment. (Record no. 27205518)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01153 a2200337 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517154549.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201810s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1098-6596 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1128/AAC.00258-17 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Anthony, R M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20181030 |
| 245 00 - TITLE STATEMENT | |
| Title | Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Antimicrobial agents and chemotherapy |
| Date of publication, distribution, etc. | 06 2017 |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Letter; Comment |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Amidohydrolases |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antitubercular Agents |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Microbial Sensitivity Tests |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mycobacterium tuberculosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrazinamide |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tuberculosis, Multidrug-Resistant |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cynamon, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hoffner, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Werngren, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | den Hertog, A L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Soolingen, D |
| 773 0# - HOST ITEM ENTRY | |
| Title | Antimicrobial agents and chemotherapy |
| Related parts | vol. 61 |
| -- | no. 6 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1128/AAC.00258-17">https://doi.org/10.1128/AAC.00258-17</a> |
| Public note | Available from publisher's website |
No items available.